Creative Medical Technology Holdings, Inc. (CELZ) vs Niki BioSolutions, Inc. (NIKI)

Creative Medical Technology Holdings, Inc. and Niki BioSolutions, Inc. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. and Niki BioSolutions, Inc. are of similar size ($6.4M and $6.2M). Niki BioSolutions, Inc. grew revenue faster over the last twelve months: 42.6% against −79.4%. Creative Medical Technology Holdings, Inc. has the higher net margin (0.00% vs −921.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Niki BioSolutions, Inc. leads on 8 and Creative Medical Technology Holdings, Inc. on 5.

Valuation

Metric CELZ NIKI Biotechnology median
P/E n/m n/m 7.88
P/S 222.10 n/m 11.47
P/B 0.44 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.38 n/m 0.74
EV/Sales (136.42) 1.25 10.73
Earnings yield (202.94%) (140.76%) (28.84%)
Free cash flow yield (297.24%) 0.00% (23.03%)

Profitability

Metric CELZ NIKI Biotechnology median
Gross margin 61.18% (87.96%) 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% (921.74%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (77.91%) 0.00% (57.72%)
Return on assets (73.30%) 0.00% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELZ NIKI Biotechnology median
Revenue growth (TTM) (79.42%) 42.64% 5.64%
EPS growth (last fiscal year) 32.08% 75.64% —
Revenue growth, 5-year CAGR (48.43%) 2.38% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ NIKI Biotechnology median
Debt to equity 0.00 0.25 0.00
Current ratio 12.91 0.78 4.73
Net debt to EBITDA 1.20 0.02 0.96

Dividend

Metric CELZ NIKI Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CELZ NIKI Biotechnology median
Market cap 6.36m 6.15m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack